TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9203944

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (16-19 mmol/l glucose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Euglycaemia (5-8 mmol/l glucose)
Number of subjects: 8
Study: 7950736

Group type: EXPERIMENTAL
Intervention: Paracetamol (1 g twice daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory drug (diclofenac 50 mg twice daily)
Number of subjects: 25
Study: 3389899

Group type: EXPERIMENTAL
Intervention: Percutaneous Silastic catheters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional intravenous cannulae
Number of subjects: 0
Study: 30725537

Group type: EXPERIMENTAL
Intervention: MUFA-rich diet
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: MED diet
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saturated fatty acid rich diet
Number of subjects: 47
Study: 28419824

Group type: EXPERIMENTAL
Intervention: Risperidone treatment for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 56
Study: 26742304

Group type: EXPERIMENTAL
Intervention: HANS group (DC pulse stimulation at acupoints JiaJi and Ciliao, 100 Hz, 15-30 mA for 30 min)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCIA group (Ondansetron 8 mg IV for 5 min, tramadol 1.5 mg/kg infusion)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCEA group (Ropivacaine 3 mg intrathecal, epidural infusion of Ropivacaine 0.1% and Sufentanil 50 ug)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 120
Study: 23411533

Group type: EXPERIMENTAL
Intervention: Lornoxicam
Number of subjects: 117

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 117
Study: 21757910

Group type: EXPERIMENTAL
Intervention: CO(2) insufflation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 60
Study: 18595519

Group type: EXPERIMENTAL
Intervention: Induced hypotension group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22472546

Group type: EXPERIMENTAL
Intervention: SNP rs10273424
Number of subjects: 729
Study: 15943962

Group type: EXPERIMENTAL
Intervention: Average pain levels for 'very satisfied' patients
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Average pain levels for 'somewhat satisfied' patients
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Average pain levels for 'slightly satisfied', 'neither satisfied nor dissatisfied', 'slightly dissatisfied', 'somewhat dissatisfied', and 'very dissatisfied' patients
Number of subjects: 207
Study: 12571176

Group type: EXPERIMENTAL
Intervention: Percutaneous pigtail catheter drainage
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (hospitalized patients)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (outpatient management)
Number of subjects: 26
Study: 9871431

Group type: COMPARATOR
Intervention: zolpidem plus placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: zolpidem plus ketoconazole
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: zolpidem plus itraconazole
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: zolpidem plus fluconazole
Number of subjects: 12
Study: 9098295

Group type: EXPERIMENTAL
Intervention: Combined (Genesis) technique of radial keratotomy
Number of subjects: 375
Study: 2815966

Group type: EXPERIMENTAL
Intervention: Trivalent split virus vaccine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Monovalent A/Taiwan/86(H1N1) vaccine
Number of subjects: 140
Study: 782310

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31663462

Group type: EXPERIMENTAL
Intervention: Smart Pill Bottle (SPB) with pharmacist intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with deactivated alerts in SPBs
Number of subjects: 40
Study: 29354972

Group type: EXPERIMENTAL
Intervention: Combination of central‐square needling technique of thumb‐tack needles with routine therapy of acupuncture, moxibustion and tuina
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine therapy of acupuncture, moxibustion and tuina
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Observation group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 26219242

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 50
Study: 23242570

Group type: EXPERIMENTAL
Intervention: EMLA(®) cream (2.5 g applied for a minimum of 30 min before venipuncture)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver during venipuncture
Number of subjects: 195

Group type: COMPARATOR
Intervention: Vaseline(®) (control group)
Number of subjects: 195
Study: 21667210

Group type: EXPERIMENTAL
Intervention: LESS TEP inguinal hernia repair
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard TEP inguinal hernia repair
Number of subjects: 54
Study: 18362868

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER (20 mg/day)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: d,l‐MPH‐ER (36 mg/day)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER and d,l‐MPH‐ER
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 16412546

Group type: EXPERIMENTAL
Intervention: Atypical neuroleptics (risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High potency neuroleptic agents (risperidone/ziprasidone/aripiprazole)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Low potency neuroleptic agents (quetiapine/olanzapine)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Atypical neuroleptics
Number of subjects: 37
Study: 12937308

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg) and clopidogrel (75 mg) daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel
Number of subjects: 200
Study: 11012555

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride 550 mg in solution alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride 550 mg in solution after 10 mg i.v. dose of metoclopramide
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride 550 mg in solution after 30 mg oral dose of propantheline
Number of subjects: 11
Study: 8598838

Group type: EXPERIMENTAL
Intervention: Saquinavir (1800 mg per day) plus zidovudine (600 mg per day) and zalcitabine (2.25 mg per day)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Zidovudine plus either saquinavir or zalcitabine
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Three-drug combination (saquinavir, zidovudine, zalcitabine)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Zidovudine and either saquinavir or zalcitabine
Number of subjects: 302
Study: 1412099

Group type: EXPERIMENTAL
Intervention: Mask without Venturi attachment at 2, 4, and 6 l/min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mask with Venturi attachments (24% and 28%) at 2 and 4 l/min
Number of subjects: 12
Study: 6443774

Group type: EXPERIMENTAL
Intervention: Cefsulodin (various dosages, including 250 mg every 6 hr)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Aminoglycoside (gentamicin, tobramycin, or amikacin)
Number of subjects: 74
Study: 28231811

Group type: EXPERIMENTAL
Intervention: Electrical somatosensory stimulation (ESS) plus usual rehabilitation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham electrical somatosensory stimulation (sham ESS) plus usual rehabilitation
Number of subjects: 102
Study: 26138593

Group type: EXPERIMENTAL
Intervention: Clazakizumab 25 mg plus MTX
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Clazakizumab 100 mg plus MTX
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Clazakizumab 200 mg plus MTX
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Clazakizumab 100 mg monotherapy
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Clazakizumab 200 mg monotherapy
Number of subjects: 418

Group type: COMPARATOR
Intervention: MTX alone (Control)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: All clazakizumab groups (25 mg, 100 mg, 200 mg)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Clazakizumab treatment groups
Number of subjects: 418
Study: 23207420

Group type: EXPERIMENTAL
Intervention: Partial removal of carious dentine (PDR)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Stepwise excavation (SW)
Number of subjects: 299
Study: 21170827

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19086197

Group type: EXPERIMENTAL
Intervention: 3D surgical planning using 3D models constructed from CT and MRI data
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3D surgical planning using 3D models
Number of subjects: 40
Study: 17169177

Group type: EXPERIMENTAL
Intervention: Laser-assisted hatching (qLZT-AH) of cryopreserved-thawed embryos (350 embryos)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Intact zona embryos (352 embryos)
Number of subjects: 702
Study: 15585557

Group type: EXPERIMENTAL
Intervention: Testosterone (Te)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 7
Study: 11518061

Group type: EXPERIMENTAL
Intervention: WS 5570 Hypericum perforatum extract 300 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: WS 5570 Hypericum perforatum extract 600 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9453276

Group type: EXPERIMENTAL
Intervention: rizatriptan 5 mg
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 247

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 247
Study: 8181115

Group type: EXPERIMENTAL
Intervention: N-terminal proANF measurement
Number of subjects: 246
Study: 3038431

Group type: EXPERIMENTAL
Intervention: Enalapril (EN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol (PPL)
Number of subjects: 0
Study: 29319408

Group type: EXPERIMENTAL
Intervention: Tremella fuciformis 600 mg/day, n=30
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tremella fuciformis 1200 mg/day, n=30
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tremella fuciformis (both doses combined)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo, n=15
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tremella fuciformis (both doses)
Number of subjects: 75
Study: 28034373

Group type: EXPERIMENTAL
Intervention: In-hospital body weight change (defined as the difference between baseline and discharge/day 10)
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Body weight change by discharge/day 10
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Weight change during hospitalization
Number of subjects: 4172

Group type: EXPERIMENTAL
Intervention: Weight change post-discharge (>1-kg increase)
Number of subjects: 4172
Study: 26571900

Group type: EXPERIMENTAL
Intervention: Shujing massage therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medication with estazolam (1 mg orally before sleep)
Number of subjects: 80
Study: 23532011

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the contralesional primary motor cortex followed by intermittent theta burst stimulation over the ipsilesional M1 (group A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Contralesional sham stimulation followed by ipsilesional real intermittent theta burst stimulation (group B)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Contralesional real 1 Hz rTMS followed by ipsilesional sham stimulation (group C)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Bilateral sham-control procedures (group D)
Number of subjects: 54
Study: 21146614

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left DLPFC (20 min at 2 mA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 10
Study: 19064533

Group type: EXPERIMENTAL
Intervention: 10.2 mg ELTP/d in a yogurt beverage for 8 weeks
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 16221944

Group type: EXPERIMENTAL
Intervention: HIQuA recommendations
Number of subjects: 213

Group type: COMPARATOR
Intervention: No query recommendations (Control)
Number of subjects: 213
Study: 12680883

Group type: EXPERIMENTAL
Intervention: 200 microg intranasal mometasone furoate (MF) once daily for 2 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 200 microg intranasal mometasone furoate (MF)
Number of subjects: 14
Study: 10333933

Group type: EXPERIMENTAL
Intervention: Walking training (WT)
Number of subjects: 169
Study: 8951626

Group type: EXPERIMENTAL
Intervention: 3% KNO3/Silica/NaF mouthwash
Number of subjects: 47

Group type: COMPARATOR
Intervention: Silica/NaF mouthwash
Number of subjects: 47
Study: 1683571

Group type: EXPERIMENTAL
Intervention: Prophylactic minitracheostomy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no minitracheostomy)
Number of subjects: 29
Study: 7030372

Group type: EXPERIMENTAL
Intervention: Penbutolol, 80 mg once a day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hydrochlorothiazide, 100 mg once a day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30132792

Group type: EXPERIMENTAL
Intervention: Bottom-up image orientation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Top-down image orientation
Number of subjects: 60
Study: 28086836

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention consisting of 10 text-based self-help sessions and one supportive email a week.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waiting control group for 12 weeks.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention.
Number of subjects: 72
Study: 26064677

Group type: EXPERIMENTAL
Intervention: Caloric Titration Method (CTM)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 162
Study: 23914211

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mg kg(‐1) for the first 10 min, followed by continuous infusion of dexmedetomidine (0.2‐0.7 μg kg(‐1) h(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam 0.2 mg kg(‐1) h(‐1) for the first 10 min, followed by continuous infusion of midazolam (0.05‐0.15 μg kg(‐1) h(‐1))
Number of subjects: 40
Study: 20233198

Group type: EXPERIMENTAL
Intervention: Prior administration of terbutaline
Number of subjects: 41
Study: 18802369

Group type: EXPERIMENTAL
Intervention: Intravenous fluid therapy (specific types not detailed, e.g., hydroxyethylstarch)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive care management strategies
Number of subjects: 0
Study: 16482787

Group type: EXPERIMENTAL
Intervention: Subcutaneously-placed, round, saline-filled prosthesis with a textured surface (Siltex and Microcell implants)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Reoperation for capsular contracture (open capsulotomy with or without implant exchange, closed compression capsulotomy)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Irradiated breasts
Number of subjects: 107

Group type: COMPARATOR
Intervention: Large-pore implants
Number of subjects: 107
Study: 12672710

Group type: EXPERIMENTAL
Intervention: 500 mg oral calcium load with serum 25OHD at 86.5 nmol/L
Number of subjects: 2

Group type: COMPARATOR
Intervention: 500 mg oral calcium load with serum 25OHD at 50 nmol/L
Number of subjects: 2
Study: 10819857

Group type: EXPERIMENTAL
Intervention: Atosiban (6.75 mg intravenous bolus, 300 microg/min for 3 hours, then 100 microg/min intravenously)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Ritodrine (0.10‐0.35 mg/min intravenously)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 247

Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Atosiban and Ritodrine
Number of subjects: 247
Study: 9289703

Group type: EXPERIMENTAL
Intervention: Monoclonal gammapathy
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Polyclonal gammapathy
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Cell immunity
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: T cell count (CD2+ and CD3+)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: T helper cells (CD4+)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: T suppressor cells (CD8+)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Patient life time
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Cause of death
Number of subjects: 82
Study: 1869345

Group type: EXPERIMENTAL
Intervention: Test preparation (sulpiride 200 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reference preparation (sulpiride 200 mg)
Number of subjects: 16
Study: 6651313

Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 51
Study: 3160869

Group type: EXPERIMENTAL
Intervention: High-dose medroxyprogesterone acetate (HD-MPA) 1200 mg p.o., b.i.d.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Mepitiostane (MS) p.o., b.i.d.
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: High-dose medroxyprogesterone acetate (HD-MPA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Mepitiostane (MS)
Number of subjects: 87
Study: 29247351

Group type: EXPERIMENTAL
Intervention: Coronary CT angiography (CCTA) during office hours
Number of subjects: 118

Group type: COMPARATOR
Intervention: Coronary CT angiography (CCTA) outside office hours
Number of subjects: 118
Study: 27627109

Group type: EXPERIMENTAL
Intervention: LPS (lipopolysaccharide endotoxin)
Number of subjects: 8
Study: 24325365

Group type: COMPARATOR
Intervention: Immediate-release (IR) formulation, 100 mg administered three times at 6-h intervals
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) formulation, 300 mg administered once to fasting subjects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) formulation, 300 mg administered once to fed subjects
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of CR to IR
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Comparison of fasting to fed for CR
Number of subjects: 50
Study: 21883710

Group type: EXPERIMENTAL
Intervention: Systemic antibiotic therapy (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No prior antibiotic therapy (n=10)
Number of subjects: 20
Study: 20545703

Group type: EXPERIMENTAL
Intervention: NNF
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 18313905

Group type: EXPERIMENTAL
Intervention: Novel lipid formulation containing fenofibrate in omega‐3 oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tricor (current marketed product)
Number of subjects: 0
Study: 16389915

Group type: EXPERIMENTAL
Intervention: Exact tests for one sample correlated binary data
Number of subjects: 0
Study: 12950522

Group type: COMPARATOR
Intervention: Etilefrine
Number of subjects: 4

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cardiac pacing
Number of subjects: 4

Group type: COMPARATOR
Intervention: Beta-blocking drugs
Number of subjects: 4
Study: 10325264

Group type: EXPERIMENTAL
Intervention: Premutation carriers
Number of subjects: 51

Group type: COMPARATOR
Intervention: Full mutation carriers
Number of subjects: 51

Group type: COMPARATOR
Intervention: Unaffected controls
Number of subjects: 51
Study: 7793549

Group type: EXPERIMENTAL
Intervention: Nellcor N200 oximeter
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Datex Satlite DS103 oximeter
Number of subjects: 36
Study: 2031913

Group type: EXPERIMENTAL
Intervention: Anorectal electromanometry in patients with NID
Number of subjects: 737
Study: 7031855

Group type: EXPERIMENTAL
Intervention: Subunit influenza vaccine (A/Victoria/75 and B/Hongkong/73)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30722039

Group type: EXPERIMENTAL
Intervention: Chronic Sleep Restriction (CSR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (8 hours sleep opportunity)
Number of subjects: 26
Study: 29750900

Group type: EXPERIMENTAL
Intervention: High-frequency (20Hz) neuronavigated-rTMS sessions
Number of subjects: 80
Study: 27053642

Group type: EXPERIMENTAL
Intervention: Imitation-based speech therapy for 6 weeks
Number of subjects: 19
Study: 24346608

Group type: EXPERIMENTAL
Intervention: Quetiapine with adjunctive personalized treatments (APTs)
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Lithium with adjunctive personalized treatments (APTs)
Number of subjects: 482
Study: 23013369

Group type: EXPERIMENTAL
Intervention: Wearing R95 activated carbon respirators
Number of subjects: 44
Study: 20171653

Group type: EXPERIMENTAL
Intervention: Montelukast (4 mg) for 3 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (matching placebo) for 3 months
Number of subjects: 200
Study: 17517005

Group type: EXPERIMENTAL
Intervention: Training parents in mediation procedures
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal parental intervention
Number of subjects: 48
Study: 16366762

Group type: EXPERIMENTAL
Intervention: Isradipine (30 mg sustained release nightly plus 15 mg immediate release 2 hr before cocaine infusion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11064229

Group type: EXPERIMENTAL
Intervention: Intensive intervention including skill training for providers, environmental orchestration (posters in clinical areas, DV questions on health questionnaires), and measurement and feedback.
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 5
Study: 9218198

Group type: EXPERIMENTAL
Intervention: Combination of verapamil and trandolapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verapamil alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trandolapril alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8233530

Group type: EXPERIMENTAL
Intervention: 1% guanethidine monosulphate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (guanethidine and water)
Number of subjects: 39